Kestra Medical Technologies, Ltd.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $99.7M | $237.6M | $8.2M |
| Accounts Receivable | $14.5M | $8.1M | $2.0M |
| Inventory | — | — | — |
| Total Current Assets | $222.4M | $255.3M | $14.9M |
| Property, Plant & Equipment | $59.1M | $34.8M | $26.1M |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $358.5M | $295.7M | $45.9M |
| Liabilities | |||
| Accounts Payable | $27.3M | $24.0M | $23.9M |
| Total Current Liabilities | $50.4M | $38.0M | $33.0M |
| Long-Term Debt | $42.6M | $41.1M | $42.5M |
| Total Liabilities | $98.8M | $90.3M | $78.2M |
| Stockholders' Equity | |||
| Retained Earnings | $-651.9M | $-520.2M | $-406.4M |
| Total Stockholders' Equity | $259.7M | $205.4M | $-209.4M |